California clinical Trials Medical Group

San Diego, California 92123

0 studies enrolling now · 3 studies all time

What they study most

Cognitive Impairment Associated With Schizophrenia, Generalized Anxiety Disorder, Schizophrenia

Studies at this site

• Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo — Stopped early
• Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects — Completed
• Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia — Status unconfirmed